Tag: Vaccines
mRNA-1273 Continues to Be Efficacious at Five Months
Vaccine efficacy was 93.2 percent for preventing COVID-19 illness, 98.2 percent for preventing severe COVID-19
Physician’s Briefing Weekly Coronavirus Roundup
Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19
All 36 neonates had high levels of anti-S IgG; in 34 of 36 neonates, levels exceeded 250 U/mL
CDC Endorses Booster Shots for Millions of Americans
Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
CDC Expert Panel to Weigh In on Vaccine Boosters
Panel will deliberate which high-risk groups should get a booster shot
U.S. to Buy 500 Million More COVID-19 Vaccine Doses for Global Donation
Some 160 million shots from the United States have been given to more than 100 countries
Moderna Vaccine Top for Protection Against COVID-19 Hospitalization
Vaccine effectiveness higher for Moderna than Pfizer-BioNTech vaccine; both mRNA vaccines have higher VE than Janssen
Booster Dose of J&J COVID-19 Vaccine May Increase Immunity
New research indicates two doses of the vaccine boosts immunity from 74 to 94 percent
